SLTM  Solta Medical Inc

Exchange

NASDAQ

Sector

Health Care

Industry

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.

168.4M

Inconsistent Cash Return on Invested Capital over the past 5 years

SLTM has somewhat efficiently invested its financial resources in buildings, projects, and equipment. However, there has been some inconsistency from year-to-year. Look at reasons for this inconsistency to determine the likelihood of future sustainability.

SLTM has created $14.17 of cash for every $100 invested.
Figures in USD. Fiscal year ends in December
20072008200920102011
Free Cash Flow 5.03M -3.43M -8.68M 8.18M -773,000.00
divided by
Invested Capital 6.62M 84.68M 89.88M 89.86M 157.42M
Cash ROIC 75.94% -4.05% -9.65% 9.11% -0.49%

Very Poor Return on Equity over the past 5 years

SLTM has shown an inability to deliver results for shareholders. This could be due to poor management, SLTM operating in a highly competitive industry, or having a weak business in general.

SLTM has generated a $4.86 loss for every $100 of Shareholders' Equity.
Figures in USD. Fiscal year ends in December
20072008200920102011
Net Income 2.78M -16.39M -11.19M -2.02M -1.33M
divided by
Stockholders' Equity 58.12M 107.82M 100.24M 122.14M 126.18M
Return on Equity 4.78% -15.20% -11.17% -1.65% -1.05%

Poor Business Performance over the past 10 years

SLTM's inability to produce positive free cash flow for the majority of the past 10 years is concerning. It should be a red flag, since this company does not have a track record of delivering results for shareholders. This could be due to poor management or the nature of its business.

SLTM has been losing money for the majority of the past 10 years.
Figures in USD. Fiscal year ends in December
2002200320042005200620072008200920102011
Free Cash Flow - - -916,000.00 -6.56M 340,000.00 5.03M -3.43M -8.68M 8.18M -773,000.00